An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,232 · see citing works

Nonparametric Estimation from Incomplete Observations

Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158 · see citing works

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,009 · see citing works

affy—analysis of Affymetrix GeneChip data at the probe level

Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221 · see citing works

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,848 · see citing works

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Paik, S., Tang, G., Shak, S., Kim, C., Baker, J. B., Kim, W., Cronin, M. T., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,576 · see citing works

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

Harris, L. N., Fritsche, H. A., Mennel, R. G., Norton, L., Ravdin, P. M., Taube, S. E., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,214 · see citing works

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126 · see citing works

Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis

Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,060 · see citing works

Genes that mediate breast cancer metastasis to the brain

Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863 · see citing works

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L. A., Ploner, A., Yudi Pawitan, Y., Hall, P. N., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,269 · see citing works

Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer

Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 995 · see citing works

Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

Desmedt, C., Piette, F., Loi, S., Wang, Y., Lallemand, F., Haibe‐Kains, B., Viale, G., Delorenzi, M., Zhang, Y., Saghatchian, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2765 · Cited by 970 · see citing works

The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer

Schmidt, M., Böhm, D., von Törne, C., Steiner, E., Puhl, A. G., Pilch, H., Lehr, H., Hengstler, J. G., KÖLBL, H., & Gehrmann, M. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5206 · Cited by 837 · see citing works

Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade

Loi, S., Haibe‐Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A. L., Bergh, J. C. S., Foekens, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1522 · Cited by 836 · see citing works

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Yudi Pawitan, Y., Bjöhle, J., Amler, L. C., Borg, A.-L., Egyházi, S., Hall, P. N., Han, X., Holmberg, L., Huang, F., Klaar, S., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1325 · Cited by 832 · see citing works

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007) · Breast Cancer Research · doi:10.1186/bcr1639 · Cited by 787 · see citing works

Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer

Ivshina, A. V., George, J., Sen'ko, O. V., Mow, B. M. F., Putti, T. C., Smeds, J., Lindahl, T., Yudi Pawitan, Y., Hall, P. N., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 751 · see citing works

Evaluation of gene expression measurements from commercial microarray platforms

Tan, P. K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg763 · Cited by 707 · see citing works

Reliability and reproducibility issues in DNA microarray measurements

DRAGHICI, S., KHATRI, P., EKLUND, A., & SZALLASI, Z. (2006) · Trends in Genetics · doi:10.1016/j.tig.2005.12.005 · Cited by 590 · see citing works

Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer

Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 566 · see citing works

Lung metastasis genes couple breast tumor size and metastatic spread

Minn, A. J., Gupta, G. P., Padua, D., Bos, P., Nguyen, D. X., Nuyten, D., Kreike, B., Zhang, Y., Wang, Y., Ishwaran, H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701138104 · Cited by 400 · see citing works

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

Loi, S., Haibe‐Kains, B., Desmedt, C., Wirapati, P., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Ryder, K., Reid, J. F., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-239 · Cited by 389 · see citing works

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Colozza, M., de Azambuja, E., Cardoso, F., Sotiriou, C. P., Larsimont, D., & Piccart, M. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi352 · Cited by 307 · see citing works

Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

Pusztai, L., Ayers, M., Stec, J. J., Clark, E. K., Hess, K. R., Stivers, D. N., Damokosh, A. I., Sneige, N., Buchholz, T. A., Esteva, F. J., et al. (2003) · PubMed · Cited by 236 · see citing works

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

Gong, Y., Yan, K., Lin, F., Anderson, K., Sotiriou, C. P., André, F., Holmes, F. A., Valero, V., Booser, D. J., Pippen, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70042-6 · Cited by 194 · see citing works

The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis

Sims, A. H., Smethurst, G. J., Hey, Y., Okoniewski, M. J., Pepper, S. D. V., Howell, A., Miller, C. J., & Clarke, R. B. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-42 · Cited by 159 · see citing works

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

Zhang, Y., Sieuwerts, A. M., McGreevy, M., Casey, G., Čufer, T., Paradiso, A., Harbeck, N., Span, P. N., Hicks, D. G., Crowe, J. P., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0183-2 · Cited by 154 · see citing works

Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy

Amat, S., Penault-Llorca, F. M., Curé, H., Bouëdec, G. L., Achard, J. L., Praagh, I. V., Feillel, V., Mouret‐Reynier, M., Dauplat, J., & Chollet, P. J. M. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.4.791 · Cited by 118 · see citing works

Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples

Győrffy, B., Molnar, B. A., Lage, H., Szállási, Z., & Eklund, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005645 · Cited by 102 · see citing works

Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients

Győrffy, B., & Schäfer, R. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0242-8 · Cited by 87 · see citing works

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

Desmedt, C., Giobbie‐Hurder, A., Neven, P., Paridaens, R., Christiaens, M., Smeets, A., Lallemand, F., Haibe‐Kains, B., Viale, G., Gelber, R. D., et al. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-40 · Cited by 81 · see citing works

Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue

Darb‐Esfahani, S., Wirtz, R. M., Sinn, B. V., Budczies, J., Noske, A., Weichert, W., Faggad, A., Scharff, S., Sehouli, J., Oskay-Özcelik, G., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0338 · Cited by 34 · see citing works

Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

Lacroix, M., Querton, G., Hennebert, P., Larsimont, D., & Leclercq, G. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1017946810277 · Cited by 23 · see citing works

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

Győrffy, B. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.014 · Cited by 1,650 · see citing works

Chromosomal instability drives metastasis through a cytosolic DNA response

Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,638 · see citing works

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

Budczies, J., Klauschen, F., Sinn, B. V., Győrffy, B., Schmitt, W., Darb‐Esfahani, S., & Denkert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051862 · Cited by 1,226 · see citing works

Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0329 · Cited by 970 · see citing works

Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement

Goodarzi, H., Liu, X., Nguyen, H. C. B., Zhang, S., Fish, L., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2015.02.053 · Cited by 949 · see citing works

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A. Y., Eyob, H., Balakrishnan, S., Wang, C., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 894 · see citing works

Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

Clarke, C., Madden, S. F., Doolan, P., Aherne, S. T., Joyce, H., O’Driscoll, L., Gallagher, W. M., Hennessy, B. T., Moriarty, M. J., Crown, J. P., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt208 · Cited by 849 · see citing works

The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism

Lu, J., Tan, M., & Cai, Q. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 800 · see citing works

Long noncoding RNA MALAT1 suppresses breast cancer metastasis

Kim, J., Piao, H.-L., Kim, B., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 772 · see citing works

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

Lánczky, A., Nagy, Á. M., Bottai, G., Munkácsy, G., Szabó, A., Santarpia, L., & Győrffy, B. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-4013-7 · Cited by 769 · see citing works

Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

Xiong, G., Deng, L., Zhu, J., Rychahou, P. G., & Xu, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-1 · Cited by 756 · see citing works

Distinct EMT programs control normal mammary stem cells and tumour-initiating cells

Ye, X., Tam, W. L., Shibue, T., Kaygusuz, Y., Reinhardt, F., Eaton, E. N., & Weinberg, R. A. (2015) · Nature · doi:10.1038/nature14897 · Cited by 697 · see citing works

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

Korpal, M., Ell, B. J., Buffa, F., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y.-L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636 · see citing works

Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome

Venet, D., Dumont, J. E., & Detours, V. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002240 · Cited by 594 · see citing works

Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells

Lee, H.-J., Zhuang, G., Cao, Y., Du, P., Kim, H.-J., & Settleman, J. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.019 · Cited by 555 · see citing works

Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors

Győrffy, B. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100625 · Cited by 480 · see citing works

Glucocorticoids promote breast cancer metastasis

Obradović, M. M. S., Hamelin, B., Manevski, N., Couto, J. P., Sethi, A., Coissieux, M.-M., Münst, S., Okamoto, R., Kohler, H., Schmidt, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1019-4 · Cited by 462 · see citing works

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

Lu, H., Clauser, K. R., Tam, W. L., Fröse, J., Ye, X., Eaton, E. N., Reinhardt, F., Donnenberg, V. S., Bhargava, R., Carr, S. A., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3041 · Cited by 457 · see citing works

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

Zheng, Y., Chen, Z., Han, Y., Li, H., Zou, X., Zhou, B., Hu, R., Hao, J., Bai, S., Xiao, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20019-0 · Cited by 460 · see citing works

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

Weng, Y.-S., Tseng, H., Chen, Y.-A., Shen, P.-C., Haq, A. T. A., Chen, L.-M., Tung, Y., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 393 · see citing works

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients

Fekete, J. T., & Győrffy, B. (2019) · International Journal of Cancer · doi:10.1002/ijc.32369 · Cited by 425 · see citing works

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

Zhang, H., Lu, H., Xiang, L., Bullen, J. W., Zhang, C., Samanta, D., Gilkes, D. M., He, J., & Semenza, G. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520032112 · Cited by 420 · see citing works

GOBO: Gene Expression-Based Outcome for Breast Cancer Online

Ringnér, M., Fredlund, E., Häkkinen, J., Borg, Å., & Staaf, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017911 · Cited by 421 · see citing works

Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

Doherty, J. R., Yang, C., Scott, K. E. N., Cameron, M. D., Fallahi, M., Li, W., Hall, M. A., Amelio, A. L., Mishra, J. K., Li, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2034 · Cited by 399 · see citing works

Tumour angiogenesis regulation by the miR-200 family

Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S. Y., Han, H., Shah, M., Rodriguez‐Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 400 · see citing works

TIM-3 regulates CD103+ dendritic cell function and response to chemotherapy in breast cancer

de Mingo Pulido, Á., Gardner, A., Hiebler, S., Soliman, H., Rugo, H. S., Krummel, M. F., Coussens, L. M., & Ruffell, B. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.019 · Cited by 388 · see citing works

Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters

Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., & Hynes, R. O. (2014) · eLife · doi:10.7554/elife.01308 · Cited by 377 · see citing works

Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival

Große-Wilde, A., d’Hérouël, A. F., McIntosh, E., Ertaylan, G., Skupin, A., Kuestner, R. E., del Sol, A., Walters, K., & Huang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126522 · Cited by 367 · see citing works

PROGgeneV2: enhancements on the existing database

Goswami, C. P., & Nakshatri, H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-970 · Cited by 369 · see citing works

p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer

Marcel, V., Ghayad, S. E., Belin, S., Thérizols, G., Morel, A., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 361 · see citing works

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling

Luo, M., Li, S., Brooks, M. D., Jiagge, E. M., Zhu, Y., Buschhaus, J. M., Conley, S. J., Fath, M. A., Davis, A., Gheordunescu, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.006 · Cited by 358 · see citing works

m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC

Jin, D., Guo, J., Wu, Y., Yang, L., Wang, X., Du, J., Dai, J., Chen, W., Gong, K., Miao, S., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01161-1 · Cited by 344 · see citing works

ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression

Wen, H., Li, Y., Xi, Y., Jiang, S., Stratton, S. A., Peng, D., Tanaka, K. Y., Ren, Y.-F., Xia, Z., Wu, J., et al. (2014) · Nature · doi:10.1038/nature13045 · Cited by 344 · see citing works

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells

Bierie, B., Pierce, S. E., Kröger, C., Stover, D. G., Pattabiraman, D. R., Thiru, P., Donaher, J. L., Reinhardt, F., Chaffer, C. L., Keckesova, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618298114 · Cited by 330 · see citing works

Protein kinase C: perfectly balanced

Newton, A. C. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1442408 · Cited by 338 · see citing works

ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types

Lehmann, W., Mossmann, D., Kleemann, J., Mock, K., Meisinger, C., Brummer, T., Herr, R., Brabletz, S., Stemmler, M. P., & Brabletz, T. (2016) · Nature Communications · doi:10.1038/ncomms10498 · Cited by 305 · see citing works

Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing

Davis, R. T., Blake, K., Ma, D., Gabra, M. B. I., Hernandez, G. A., Phung, A. T., Yang, Y., Maurer, D., Lefebvre, A. E. Y. T., Alshetaiwi, H. S., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0477-0 · Cited by 298 · see citing works

Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression

Maller, O., Drain, A. P., Barrett, A. S., Borgquist, S., Ruffell, B., Zakharevich, I., Pham, T. T. M., Gruosso, T., Kuasne, H., Lakins, J. N., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-00849-5 · Cited by 295 · see citing works

LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress

Liu, X., Xiao, Z., Han, L., Zhang, J., Lee, S.-W., Wang, W., Lee, H., Zhuang, L., Chen, J., Lin, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3328 · Cited by 289 · see citing works

Elf5 inhibits the epithelial–mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2

Chakrabarti, R., Hwang, J., Blanco, M. A., Wei, Y., Lukačišin, M., Romano, R. A., Smalley, K., Liu, S., Yang, Q., Ibrahim, T., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2607 · Cited by 285 · see citing works

Simultaneous Multiplexed Imaging of mRNA and Proteins with Subcellular Resolution in Breast Cancer Tissue Samples by Mass Cytometry

Schulz, D., Zanotelli, V. R., Fischer, J. R., Schapiro, D., Engler, S., Lun, X., Jackson, H. W., & Bodenmiller, B. (2017) · Cell Systems · doi:10.1016/j.cels.2017.12.001 · Cited by 279 · see citing works

Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance

Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K. L., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 277 · see citing works

Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis

Godet, I., Shin, Y. J., Ju, J. A., Ye, I. C., Wang, G., & Gilkes, D. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12412-1 · Cited by 274 · see citing works

The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy

Lelièvre, P., Sancey, L., Coll, J., Deniaud, A., & Busser, B. (2020) · Cancers · doi:10.3390/cancers12123594 · Cited by 273 · see citing works

STAT3, stem cells, cancer stem cells and p63

Galoczová, M., Coates, P. J., & Vojtěšek, B. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0078-0 · Cited by 266 · see citing works

SALMON: survival analysis learning with multi-omics neural networks on breast cancer

Huang, Z., Zhan, X., Xiang, S., Johnson, T. S., Helm, B., Yu, C. Y., Zhang, J., Salama, P., Rizkalla, M., Han, Z., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00166 · Cited by 262 · see citing works

DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

Pathania, R., Ramachandran, S., Elangovan, S., Padia, R. N., Yang, P., Cinghu, S., Veeranan‐Karmegam, R., Arjunan, P., Gnana‐Prakasam, J. P., Fulzele, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7910 · Cited by 259 · see citing works

Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor Suppression

Liu, Z., Chen, P., Gao, H., Gu, Y., Yang, J., Peng, H., Xu, X., Wang, H., Yang, M., Liu, X., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.015 · Cited by 254 · see citing works

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression

Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13007 · Cited by 239 · see citing works

Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer

Jansen, V. M., Bhola, N. E., Bauer, J. A., Formisano, L., Lee, K., Hutchinson, K. E., Witkiewicz, A. K., Moore, P. D., Estrada, M. V., Sanchez, V. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2653 · Cited by 245 · see citing works

Dissecting the expression landscape of RNA-binding proteins in human cancers

Kechavarzi, B., & Janga, S. C. (2014) · Genome biology · doi:10.1186/gb-2014-15-1-r14 · Cited by 242 · see citing works

Patterns of ribosomal protein expression specify normal and malignant human cells

Guimaraes, J. C., & Zavolan, M. (2016) · Genome biology · doi:10.1186/s13059-016-1104-z · Cited by 233 · see citing works

ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis

Shanbhag, V., Jasmer, K. J., Zhu, S., Martin, A. L., Gudekar, N., Khan, A. A., Ladomersky, E., Singh, K., Weisman, G. A., & Petris, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817473116 · Cited by 237 · see citing works

Identification of Novel Genetic Markers of Breast Cancer Survival

Guo, Q. J., Schmidt, M. K., Kraft, P., Canisius, S., Chen, C., Khan, S., Tyrer, J. P., Bolla, M. K., Wang, Q., Dennis, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv081 · Cited by 234 · see citing works

Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

Khongkow, P., Gomes, A., Gong, C., Man, E. P. S., Tsang, J. W.-H., Zhao, F., Monteiro, L. J., Coombes, R. C., Medema, R. H., Khoo, U., et al. (2015) · Oncogene · doi:10.1038/onc.2015.152 · Cited by 233 · see citing works

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

Garg, A. D., Ruysscher, D. D., & Agostinis, P. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069938 · Cited by 229 · see citing works

TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis

Zhang, L., Zhou, F., de Vinuesa, A. G., de Kruijf, E. M., Mesker, W. E., Li, H., Drabsch, Y., Li, Y., Bauer, A., Rousseau, A., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.014 · Cited by 224 · see citing works

TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription

Yu, J., Sun, W., Wang, Z., Liang, X., Hua, F., Li, K., Lv, X., Zhang, X., Liu, Y., Yu, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13700-6 · Cited by 228 · see citing works

SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis

Tang, X., Shi, L., Xie, N., Liu, Z., Qian, M., Meng, F., Xu, Q.-Y., Zhou, M., Cao, X., Zhu, W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00396-9 · Cited by 224 · see citing works

Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses

Pardo-Pastor, C., Rubio-Moscardó, F., Vogel-González, M., Serra, S. A., Afthinos, A., Mrkonjić, S., Destaing, O., Abenza, J. F., Fernández‐Fernández, J. M., Trepat, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718177115 · Cited by 224 · see citing works

Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis

McCaffrey, L. M., Montalbano, J., Mihai, C., & Macara, I. G. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.003 · Cited by 218 · see citing works

PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis

Zheng, H., Shen, M., Zha, Y.-L., Li, W., Wei, Y., Blanco, M. A., Ren, G., Zhou, T., Störz, P., Wang, H., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.022 · Cited by 218 · see citing works

Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia

Gallagher, E. J., Zelenko, Z., Neel, B. A., Antoniou, I. M., Rajan, L., KASE, N. G., & LeRoith, D. (2017) · Oncogene · doi:10.1038/onc.2017.247 · Cited by 218 · see citing works

A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo

Mele, L. L., Paino, F., Papaccio, F., Regad, T., Boocock, D. J., Stiuso, P., Lombardi, A., Liccardo, D., Aquino, G., Barbieri, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0635-5 · Cited by 215 · see citing works

What turns CREB on? And off? And why does it matter?

Steven, A., Friedrich, M., Jank, P., Heimer, N., Budczies, J., Denkert, C., & Seliger, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03525-8 · Cited by 214 · see citing works

PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression

Chiang, K., Zielinska, A. E., Shaaban, A. M., Sánchez-Bailón, M. P., Jarrold, J., Clarke, T. L., Zhang, J., Francis, A., Jones, J. L., Smith, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.096 · Cited by 208 · see citing works

Kinesin Family Deregulation Coordinated by Bromodomain Protein ANCCA and Histone Methyltransferase MLL for Breast Cancer Cell Growth, Survival, and Tamoxifen Resistance

Zou, J. X., Duan, Z., Wang, J., Sokolov, A., Xu, J., Chen, C. Z., Li, J. J., & Chen, H.-W. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0459 · Cited by 202 · see citing works

CD74 and intratumoral immune response in breast cancer

Wang, Z., Milne, K., Webb, J. R., & Watson, P. H. (2016) · Oncotarget · doi:10.18632/oncotarget.8610 · Cited by 202 · see citing works

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling

Tang, X., Hou, Y., Yang, G., Wang, X., Tang, S., Du, Y.-E., Yang, L., Yu, T., Zhang, H., Zhou, M., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.78 · Cited by 200 · see citing works

Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter

Hou, G., Liu, P., Yang, J., & Wen, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174515 · Cited by 198 · see citing works

PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer

Magnani, L., Ballantyne, E. B., Zhang, X., & Lupien, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002368 · Cited by 193 · see citing works

A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors

Cui, X., Zhang, X., Liu, M., Zhao, C., Zhang, N., Ren, Y., Su, C., Zhang, W., Sun, X., He, J., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.06.044 · Cited by 194 · see citing works

Extracellular superoxide dismutase and its role in cancer

Griess, B., Tom, E. C., Domann, F. E., & Teoh-Fitzgerald, M. L. T. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.013 · Cited by 195 · see citing works

Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?

Cancel, J.-C., Crozat, K., Dalod, M., & Mattiuz, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00009 · Cited by 190 · see citing works

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy

Zhang, W., Mao, J., Zhu, W., Jain, A. K., Liu, K., Brown, J. B., & Karpen, G. H. (2016) · Nature Communications · doi:10.1038/ncomms12619 · Cited by 192 · see citing works

Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs

Pein, M., Insua‐Rodríguez, J., Hongu, T., Riedel, A., Meier, J., Wiedmann, L., Decker, K., Essers, M. A. G., Sinn, H., Spaich, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15188-x · Cited by 192 · see citing works

A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer

Mihály, Z., Kormos, M., Lánczky, A., Dank, M., Budczies, J., Szász, M. A., & Győrffy, B. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2622-y · Cited by 190 · see citing works

Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis

Wishart, A. L., Conner, S. J., Guarin, J. R., Fatherree, J. P., Peng, Y., McGinn, R. A., Crews, R., Naber, S. P., Hunter, M., Greenberg, A. S., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3175 · Cited by 187 · see citing works

Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma

Wang, H., Liang, L., Dong, Q., Huan, L., He, J., Li, B., Yang, C. G., Jin, H., Wei, L., Yu, C., et al. (2018) · Theranostics · doi:10.7150/thno.23012 · Cited by 186 · see citing works

FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer

Huang, Y., Zhang, H., Li, Z., Du, T., Chen, Y., Wang, Y., Ni, H.-H., Zhang, K., Mai, J., Hu, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22618-x · Cited by 186 · see citing works

Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer

Magnani, L., Stoeck, A., Zhang, X., Lánczky, A., Mirabella, A., Wang, T., Győrffy, B., & Lupien, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219992110 · Cited by 181 · see citing works

NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction

Lu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., Huo, Y., Kensler, T. W., Gatza, M. L., & Xia, B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2204 · Cited by 178 · see citing works

STRIPAK components determine mode of cancer cell migration and metastasis

Madsen, C. D., Hooper, S., Tozluoǧlu, M., Bruckbauer, A., Fletcher, G., Erler, J. T., Bates, P. A., Thompson, B. J., & Sahai, E. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3083 · Cited by 172 · see citing works

Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism

Budczies, J., Brockmöller, S. F., Müller, B. M., Barupal, D. K., Richter-Ehrenstein, C., Kleine-Tebbe, A., Griffin, J. L., Orešič, M., Dietel, M., Denkert, C., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.002 · Cited by 175 · see citing works

Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities

Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 175 · see citing works

Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.

Guo, X., Wang, X., Wang, Z., Banerjee, S., Yang, J., Huang, L., & Dixon, J. E. (2016) · Nature Cell Biology · doi:10.1038/ncb3289 · Cited by 169 · see citing works

Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression

Xu, Y., Qin, L., Sun, T., Wu, H., He, T., Yang, Z., Mo, Q., Liao, L., & Xu, J. (2016) · Oncogene · doi:10.1038/onc.2016.286 · Cited by 174 · see citing works

ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer

Kumar, S., Wilkes, D. W., Samuel, N., Blanco, M. A., Nayak, A., Alicea-Torres, K. M., Gluck, C. B., Sinha, S., Gabrilovich, D. I., & Chakrabarti, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99673 · Cited by 174 · see citing works

WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer

Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M. N., Jardon, M. L., Hardie, N., Loddenkemper, C., Ulasov, I. V., Lesniak, M. S., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201320 · Cited by 171 · see citing works

IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel

Wee, Z. N., Yatim, S. M. J. M., Kohlbauer, V., Feng, M., Goh, J. Y., Bao, Y., Lee, P. L., Zhang, S., Wang, P. P., Lim, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms9746 · Cited by 170 · see citing works

Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes

Forero, A., Li, Y., Chen, D., Grizzle, W. E., Updike, K. L., Merz, N. D., Downs-Kelly, E. P., Burwell, T. C., Vaklavas, C., Buchsbaum, D. J., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0243 · Cited by 170 · see citing works

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Fu, X., Jeselsohn, R. M., Pereira, R., Hollingsworth, E. F., Creighton, C. J., Li, F., Shea, M. J., Nardone, A., Angelis, C. D., Heiser, L. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612835113 · Cited by 169 · see citing works

Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment

Lu, H., Chen, I., Shimoda, L. A., Park, Y., Zhang, C., Tran, L., Zhang, H., & Semenza, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.001 · Cited by 168 · see citing works

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

Li, H., Liang, J.-L., Kuo, Y., Lee, H.-H., Calkins, M. J., Chang, H.-T., Lin, F., Chen, Y., Hsu, T., Hsiao, M., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0918-2 · Cited by 168 · see citing works

Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line

Li, C., Rezania, S., Kammerer, S., Sokolowski, A., DeVaney, T. T. J., Gorischek, A., Jahn, S. W., Hackl, H., Groschner, K., Windpassinger, C., et al. (2015) · Scientific Reports · doi:10.1038/srep08364 · Cited by 164 · see citing works

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Fu, X., Pereira, R., Angelis, C. D., Veeraraghavan, J., Nanda, S., Qin, L., Cataldo, M. L., Sethunath, V., Mehravaran, S., Gutiérrez, C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911584116 · Cited by 163 · see citing works

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

Achinger-Kawecka, J., Valdés‐Mora, F., Luu, P., Giles, K. A., Caldon, C. E., Qu, W., Nair, S. S., Soto, S., Locke, W. J., Yeo-Teh, N. S. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14098-x · Cited by 162 · see citing works

P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-p1-07-18 · Cited by 70 · see citing works

Online biomarker validation of survival-associated biomarkers in breast and ovarian cancer using microarray data of 3,862 patients.

Győrffy, B., Lánczky, A., & Szállási, Z. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.10571

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Sotiriou, C. P., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A. A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993 · see citing works

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

van Laar, R. K. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.003 · Cited by 12 · see citing works

bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer

Jézéquel, P., Campone, M., Gouraud, W., Guérin‐Charbonnel, C., Leux, C., Ricolleau, G., & Campion, L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1457-7 · Cited by 410 · see citing works